Clasado Biosciences   Report issue

For profit Phase 3
Founded: Shinfield United Kingdom (2004)

Organization Overview

First Clinical Trial
2009
NCT01004120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clasado | Clasado Biosciences Ltd | Clasado Limited | Clasado Research Services | Clasado Research Services Limited

Active Ingredients

Drugs in Phase 3 Trials (2)

galactooligosaccharide (11 trials)

maltodextrin (1 trial)

Drugs in Other Trials (3)

gluco-galacto-oligosaccharide (1 trial)

human milk (1 trial)

inulin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autism Spectrum Disorder (Phase 1)

Autistic Disorder (Phase 1)

Diarrhea (Phase 3)

Dysentery (Phase 3)

Metabolic Syndrome (Phase 2)

Overweight (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 5